logo
#

Latest news with #Elisabeth

2-year-old in coma after E. coli infection from Oklahoma lake. ‘Blows our minds'
2-year-old in coma after E. coli infection from Oklahoma lake. ‘Blows our minds'

Miami Herald

time18-06-2025

  • Health
  • Miami Herald

2-year-old in coma after E. coli infection from Oklahoma lake. ‘Blows our minds'

A 2-year-old girl contracted E. coli at an Oklahoma lake and is now fighting for her life as complications from the infection takes its toll on her body, her family says. 'It's a nightmare, and it happened so fast — within like a week, we're here,' said Suzanne Faircloth, the mother of Elisabeth Faircloth, who became ill after swimming in Keystone Lake in early June, KOTV reported. According to a GoFundMe, Elisabeth is battling kidney failure and is 'fighting every day to stay with us.' Elisabeth's sister, Grayson Faircloth, said the virus has been attacking other organs as well, including her liver. Melissa Lynne, Elisabeth's aunt, said in a Facebook post her niece was diagnosed with Hemolytic-Uremic Syndrome and is fighting three different strains of E. coli. 'She is currently on dialysis and has been medically paralyzed in order to give her little body the best chance at conquering this thing,' Lynne said. 'Although the prognosis is hopeful, it will be a very long battle to get her well again and it's uncertain if she will ever recover 100% or if there will be permanent kidney and/or brain damage.' The Mayo Clinic says Hemolytic-Uremic Syndrome, also called HUS, can cause blood clots throughout the body 'when small blood vessels become damaged and inflamed.' Young children are most susceptible to HUS, and certain E. coli strains are often the cause. In a June 17 update, Kelly Faircloth said Elisabeth was now awake, but the infection had begun attacking her lungs. 'It blows our minds, because we've never even heard of anything like this ever happening,' Elisabeth's mother told KOTV. 'We've heard of E. coli — but usually in hamburgers.' Multiple waterways in Oklahoma were reported to have elevated levels of E. coli when water samples were collected May 23, according to the Grand River Dam Authority. Those waterways did not include Keystone Lake, located about a 25-mile drive northwest from Tulsa, but the River Parks Authority announced June 10 that Zink Lake would be closed 'due to unsafe water conditions from high Keystone Dam releases.' Children under 5 are among the groups of people most likely to be infected with E. coli, according to the Centers for Disease Control and Prevention. Most E. coli bacteria are harmless, the CDC says, but others cause sickness and the risk of HUS.

NodThera Announces Appointment of Elisabeth Björk as Board Member
NodThera Announces Appointment of Elisabeth Björk as Board Member

Yahoo

time17-06-2025

  • Business
  • Yahoo

NodThera Announces Appointment of Elisabeth Björk as Board Member

NodThera Announces Appointment of Elisabeth Björk as Board Member Philadelphia, PA, June 17, 2025 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic inflammatory diseases through selective modulation of the NLRP3 inflammasome, today announces the appointment of Elisabeth Björk, M.D., Ph.D. as Board Member. Elisabeth has more than 20 years of experience in late-stage clinical development, global regulatory submissions and successful drug commercialization, with particular strengths in cardiovascular and metabolic disease. She most recently served as Senior Vice President (SVP), Head of Obesity franchise at AstraZeneca (LON: AZN), where she led the development of AZD5004, a small molecule oral GLP-1 receptor agonist, and drove portfolio strategy development for obesity, weight management, diabetes, and cardiorenal protection. While at AstraZeneca, Elisabeth also held senior CVRM (Cardiovascular, Renal and Metabolism) leadership roles including SVP, Head of late phase CVRM R&D. In this role she was instrumental in transforming the disease area from the treatment of individual risk factors to broad cardiorenal protection, bringing several blockbuster drugs to patients. Elisabeth also co-chaired the Therapy Area Leadership Team setting strategy across research and commercial functions, delivering global late-stage portfolio and life cycle management programs, and serving as global line leader for CVRM clinical development personnel. Her leadership was pivotal in building AstraZeneca's world-class CVRM portfolio and establishing one of the industry's leading R&D sites in Gothenburg, Sweden, where she served as site lead. Daniel Swisher, Chief Executive Officer of NodThera, said: "We are thrilled to welcome Elisabeth to our Board of Directors. Her exceptional track record in the obesity and broader cardiometabolic fields, setting and executing strategy, and bringing transformative medicines to patients, will be invaluable as we advance our brain-penetrant NLRP3 inflammasome inhibitors further through clinical development. Elisabeth's deep scientific and commercial understanding, in a therapeutic focus area that is so important to NodThera, will bring tremendous value to the advancement of our programs and our evolution into a mature, high-value clinical-stage company." Elisabeth Björk, MD, PhD, commented: "I am delighted to join NodThera's Board of Directors at this critical point in the company's journey. The potential to selectively modulate the NLRP3 inflammasome to reset the body's metabolic pathways represents a compelling therapeutic opportunity with significant implications for patients suffering from chronic inflammatory diseases. With my drug development experience, I look forward to supporting the talented and experienced management team as they advance their innovative therapies to market." Elisabeth currently serves on the Boards of several public and private companies, including Rocket Pharmaceuticals (NASDAQ: RCKT), Pharvaris N.V. (NASDAQ: PHVS), Vicore Pharma AB (STO: VICO), Camurus AB (STO: CAMX), and Ousia Pharma ApS. Elisabeth holds an M.D. from the Karolinska Institute and a Ph.D. in Endocrinology from Uppsala University, where she also served as Associate Professor of Medicine. For more information about NodThera please contact: NodTheraTel: +44 (0) 1223 608130Email: info@ ICR Healthcare Amber Fennell, David Daley Tel: +44 (0)20 3709 5700Email: nodthera@ About NodTheraNodThera is a leading clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases. Led by an experienced management team, NodThera is combining a deep understanding of NLRP3 inhibition, pharmaceutical neuroscience expertise and precision chemistry. Its two lead clinical candidates are oral, small molecule NLRP3 inflammasome inhibitors, which have demonstrated differentiated, potentially best-in-class clinical profiles with significant anti-inflammatory effects and high brain penetration, offering distinct opportunities to treat multiple indications. The Company is backed by top-tier investors including 5AM Ventures, Blue Owl Capital, Epidarex Capital, F-Prime Capital, Novo Holdings, Sanofi Ventures and Sofinnova Partners. NodThera is headquartered in Philadelphia, Pennsylvania, with additional operations in Cambridge, UK. Learn more at or follow the Company on in to access your portfolio

A Guide to Glacier National Park, According to a Regular Visitor
A Guide to Glacier National Park, According to a Regular Visitor

Condé Nast Traveler

time12-06-2025

  • Condé Nast Traveler

A Guide to Glacier National Park, According to a Regular Visitor

If the 10 million acres of peaks, rivers, and lakes spanning northern Montana and southwestern Canada is the Crown of the Continent, then Glacier National Park is that crown's sparkliest jewel. Hugging the Continental Divide and encompassing 1,583 square miles of remote glacial lakes, rose-tinged mountains, and trout-filled rivers, Glacier is epic in the truest sense of the word. The ecosystems of the park remain relatively undisturbed, home to the same plants and animals that have been here for centuries—grizzly bears, mountain goats, wolverines, and wolves among them—and tribes like the Blackfeet, Séliš, Ql̓ispé, and Ksanka maintain deep ties to their ancestral lands. Travelers can hike into the backcountry, cruise lofty heights on Going-to-the-Sun Road, and lounge by a sapphire lake, making a visit as wild, or as refined, as desired. No matter how you choose to spend your time in Glacier, the park is sure to treat you like royalty. Elisabeth Kwak-Hefferan Elisabeth Kwak-Hefferan is an award-winning freelance writer and editor who focuses on climate solutions, environment, the outdoors, travel, and parenting. Born and raised in the Chicagoland area, she now makes her home in Missoula, Montana. Elisabeth holds a Master's degree in magazine journalism from Northwestern University's Medill School of Journalism, where she earned the prestigious McCormick Scholar designation and the Harrington Memorial Award. Her most ambitious trip to date was taking two kids under five on a two-week jaunt around England and Ireland (nobody slept much, but it was worth it). Of the dozens of national parks I've visited, Glacier is my favorite. My husband and I got engaged in a tent alongside Gunsight Lake, and we've watched our kids go from exploring Logan Pass while riding in a baby carrier to confidently hiking Avalanche Lake under their own power (mostly). We make the trip up there at least once a year to sleep under the stars, canoe the lakes, and count how many mountain goats we can see. Over the years, we've found our favorite nooks and crannies. Below, I share them all, in this guide to Glacier National Park. What's new in 2025 The Swiftcurrent area at Many Glacier will be under construction for road and water system repairs until spring 2026. Visitors can still access the area, but only those with Many Glacier Hotel or activity reservations will be allowed to park there from July through September. Everyone else must park along the entrance road and ride a shuttle into the heart of Many Glacier ($2 reservation required; book at

Search for missing vulnerable Christchurch woman continues
Search for missing vulnerable Christchurch woman continues

RNZ News

time09-06-2025

  • RNZ News

Search for missing vulnerable Christchurch woman continues

The 79-year old called Elisabeth was last seen on Barlett Street in Riccarton last night. Photo: Supplied Police say they are looking for new leads as they continue their search for a vulnerable Christchurch woman missing since Wednesday night. Elisabeth, who is 79, and has distinctive long white hair, disappeared after walking out of the Margaret Stoddart Retirement Village on Bartlett Street in Riccarton. A police spokesperson said officers were working to establish "any new areas of interest", and they urged anyone with any information about her whereabouts, "no matter how small", to come forward. Elisabeth, 79, was last seen on Bartlett Street in Riccarton about 6pm on Wednesday 4 June. She was wearing blue pants, a dark coloured long-sleeve top, black shoes and has distinctive long blond/white hair. Photo: Supplied/NZ Police "If you have seen Elisabeth or have any information about where she could be, please call 105 and quote reference number 250604/5465." Elizabeth was wearing blue trousers and a dark coloured long-sleeved top when she was last seen.

Police still following tips to find missing Christchurch woman after calling off formal search
Police still following tips to find missing Christchurch woman after calling off formal search

RNZ News

time06-06-2025

  • RNZ News

Police still following tips to find missing Christchurch woman after calling off formal search

The 79-year old called Elisabeth was last seen on Bartlett Street in Riccarton on Wednesday night. Photo: Supplied Police are still following tips from the public to find a missing 79-year-old after having called off the formal search on Friday. The woman, Elisabeth, disappeared after walking out of the Margaret Stoddart Retirement Village in Riccarton on Wednesday. She had been admitted that day for respite care. A spokesperson said the police were actively following up information from the public, but had not substantiated any sightings since Elisabeth was last seen on Wednesday. Elisabeth was wearing blue pants, a dark coloured long-sleeved top, black shoes and had distinctive long blonde/white hair. Anyone who sees Elisabeth should ring 111 immediately and use the reference number 250604/5465. Non-urgent information can be provided online here , using Update Report, and quoting the same reference number. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store